Cenix BioScience and Integromics awarded EU FP7
EuroTransBio grant to co-develop integrated data analysis environment
for HT-RNAi screening.
Dresden, Germany, November 11, 2010
- Cenix BioScience GmbH today announced that it and collaborator
Integromics S.L. (Madrid, Spain; www.integromics.com) have
together secured a research
grant from the EuroTransBio initiative of the European Commission’s
Seventh Framework Program, for a project entitled “Integrated
computational environment for high throughput RNA interference
screening”. In the 3-year grant, which includes 454,000 Euro funding
for Cenix, both companies will jointly develop a novel platform for
processing, organizing and analyzing complex datasets from high
throughput (HT), high content (HC) screening.
project builds on the leading expertise of Cenix in the field of
HT-RNAi screening using microscopy-based HC readouts, and integrates
cutting edge software solutions from Integromics together with the
powerful data processing workflow engine KNIME and the industry
standard platform for interactive data visualization Spotfire. For
Cenix, the project represents another important step in its core
efforts to continually enhance its leading RNAi-based contract research
offerings, while Integromics will look to commercialize elements of the
platform as bioinformatics applications to customers in the academic
and industrial sectors.
Cenix and the Cenix BioScience logo are registered trademarks owned
by Cenix BioScience GmbH in the US and other countries.
KNIME is a registered trademark owned by KNIME.com GmbH.
Spotfire is a registered trademark owned by TIBCO Software Inc.